JPWM
BIIB icon

Jamison Private Wealth Management’s Biogen BIIB Stock Holding History

Jamison Private Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-162
Closed -$31.4K – 231
2024
Q3 		$31.4K Hold
162
– – ﹤0.01% 278
2024
Q2 		$37.6K Sell
162
-203
-56% -$44.1K 0.01% 257
2024
Q1 		$78.7K Hold
365
– – 0.01% 230
2023
Q4 		$94.5K Hold
365
– – 0.02% 206
2023
Q3 		$93.8K Buy
+365
New +$97.6K 0.02% 202

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jamison Private Wealth Management's BIIB Position: Q4 2024 in Review

Jamison Private Wealth Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 162 shares — an estimated $31.4K sold.

Jamison Private Wealth Management first reported a position in BIIB in Q3 2023 and held it in 5 quarters. The position peaked at $94.5K in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Jamison Private Wealth Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Jamison Private Wealth Management sold 162 Biogen shares in Q4 2024, an estimated $31.4K.
  • Jamison Private Wealth Management first reported a position in Biogen in Q3 2023 and held it in 5 quarters.
  • Jamison Private Wealth Management's Biogen position peaked at $94.5K in Q4 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Jamison Private Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.